Sumitomo Chemical India Limited

NSE:SUMICHEM.NS

586.5 (INR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q3
Revenue 8,388.876,742.045,420.219,034.797,242.436,501.217,536.5311,216.679,855.276,407.757,071.759,103.747,819.955,170.865,609.149,020.136,476.954,195.025,231.28,295.696,253.334,217.264,321.54
Cost of Revenue 5,928.634,686.793,265.35,569.415,724.634,474.234,8736,967.436,391.634,200.624,414.935,555.184,996.333,472.513,498.625,419.324,226.472,960.553,562.895,393.054,221.533,094.772,964.21
Gross Profit 2,460.242,055.252,154.913,465.381,517.82,026.982,663.534,249.243,463.642,207.132,656.823,548.562,823.621,698.352,110.523,600.812,250.481,234.471,668.312,902.642,031.81,122.491,357.33
Gross Profit Ratio 0.2930.3050.3980.3840.210.3120.3530.3790.3510.3440.3760.390.3610.3280.3760.3990.3470.2940.3190.350.3250.2660.314
Reseach & Development Expenses 013.4200011.2500012.030007.840006.650000.610
General & Administrative Expenses 0434.02000585.13000533.82000455.69000530.05000555.440
Selling & Marketing Expenses 0387.14000468.26000398.61000346.64000407.55000436.330
SG&A 997.89821.16957.77997.15846.721,053.39935.69925.671,015.62932.43518.31454.41783.8802.33495.08540.83483.38937.6445.86444.3437.77991.77391.68
Other Expenses 260.11267.02268.68245.68175.31164.82131.74105.371,700.49-181.6461.5278.5154.28-126.9954.4661.3623.21-3.211.4243.7910.1400
Operating Expenses 997.89821.161,657.911,743.69846.721,361.631,573.081,6211,700.491,199.041,505.611,511.081,436.22868.361,440.891,524.791,171.15871.131,306.951,398.871,274.06978.651,224.95
Operating Income 1,462.351,234.09765.681,967.37671.08666.81,222.192,733.611,809.73990.111,151.212,037.481,387.4829.99669.632,076.021,079.33340.98372.781,503.77757.74264.54113.17
Operating Income Ratio 0.1740.1830.1410.2180.0930.1030.1620.2440.1840.1550.1630.2240.1770.1610.1190.230.1670.0810.0710.1810.1210.0630.026
Total Other Income Expenses Net 248.2253.92-12.17-12.44161.95149.44-13.12-13.76-13.1351.2345.3958.4636.03-215.8739.5244.579.8-24.88-265.71-9.16-10.31-84.2311.55
Income Before Tax 1,710.551,488.01753.511,954.93833.03816.241,209.072,719.851,796.61,041.341,196.62,095.941,423.43614.12709.152,120.591,089.13316.1107.071,494.61747.43180.31124.72
Income Before Tax Ratio 0.2040.2210.1390.2160.1150.1260.160.2420.1820.1630.1690.230.1820.1190.1260.2350.1680.0750.020.180.120.0430.029
Income Tax Expense 443.65389.06206.26520.47216.2594.95304.24705.2415.28294.81307.32553.79365.9473.14167.68542.99295.1287.04100.29217.13213.8191.49108.54
Net Income 1,266.761,097.04547.131,434.46616.78721.29904.832,014.651,381.32746.59889.311,542.171,057.47540.98541.471,577.6794.01229.066.781,277.48533.63-11.1816.18
Net Income Ratio 0.1510.1630.1010.1590.0850.1110.120.180.140.1170.1260.1690.1350.1050.0970.1750.1230.0550.0010.1540.085-0.0030.004
EPS 2.542.21.12.871.241.451.814.042.771.51.783.092.121.081.083.161.590.460.0142.561.07-0.0230.03
EPS Diluted 2.542.21.12.871.241.451.814.042.771.51.783.092.121.081.083.161.590.460.0142.561.07-0.0230.03
EBITDA 1,610.991,401.82926.862,125.09806.34970.531,336.12,885.691,922.161,148.61,326.612,225.251,552.17876.53834.672,249.91,209.3470.41470.121,640.85857.52329.105168.525
EBITDA Ratio 0.1920.2080.1710.2350.1110.1490.1770.2570.1950.1790.1880.2440.1980.170.1490.2490.1870.1120.090.1980.1370.0780.039